Rev ALAD ; Looker HC, Nyangoma SO, Cromie D et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia Title: Revista ALAD Volumen 5 Número 1, Author: Asociacion Latinoamericana de Diabetes, En: 4th World Congr Controv Diabetes Obes Hypertens KDOQI Clinical Practice Guideline for Diabetes and CKD: update. Am J Kidney Dis ; Guías ALAD sobre el diagnóstico, control y.

Author: Kebar Mazutaur
Country: Switzerland
Language: English (Spanish)
Genre: Career
Published (Last): 21 January 2005
Pages: 267
PDF File Size: 20.93 Mb
ePub File Size: 3.70 Mb
ISBN: 308-5-65749-747-4
Downloads: 57778
Price: Free* [*Free Regsitration Required]
Uploader: Kaganos

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

Diab Vasc Dis Res ; 9: Managed care perspective on three new agents for type 2 diabetes. Dipeptidylpeptidase 4 DPP-4 inhibitors duabetes type 2 diabetes mellitus. N Eng J Med ; 3: Fish diabeyes in people with type 2 diabetes mellitus. Physical activity and prevention of type 2 diabetes mellitus. Clinical Practice Guidelines A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.

Primera Encuesta Nacional de Factores de Riesgo.

Asociación Latinoamericana de Diabetes – ALAD

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: Nissen S, Wolski N. Sociedad Argentina de Diabetes. Am J Clin Nutr ; 67 Suppl 1: Glycemic control continues to deteriorate after sulfonylureas are added to metformin in patients with type 2 diabetes.


Obes Surg,4: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids: Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes.

First Word Pharma, 28, August Diabetes Res Clin Pract ; 2: N Engl J Med3: Medical management of hyperglycemia in type 2 diabetes: Kidney Int ; Diabetes Metab ; New Engl J Med Finding new treatments for diabetes: Diabetes Obes Metab ; IDF Global guideline for managing older people with type 2 diabetes.

There was a problem providing the content you requested

Efficacy and safety of initial combination theraphy with sitagliptin and metformin in patients with type 2 diabetes: Herman W, Johnson J, et al.

N Eng J Med ; Prevalence 0212 diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina.

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. Adv Ther ; A randomized trial of insulin aspart versus human insulin in pregnant women. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and diabettes serum lipids and apolipoproteins: Management of hyperglycaemia in type 2 diabetes: Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.


Diabetes Rev6: Bariatric surgery versus intensive medical therapy for diabetesyear outcomes. Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus.

Cochrane Database Syst Rev, Intensive blood glucose control with sulphonyureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33 Lancet ; Revista de la ALAD, Exercise for type 2 diabetes mellitus. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Herman W, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes.

Global estimates of diabetes prevalence for and projections for